文献速递中毒与环境急症消化、代谢与肾脏急症

文拉法辛中毒的剂量相关性低血糖:一项回顾性队列研究

Dose-related hypoglycemia in venlafaxine poisoning: a retrospective cohort study.
PubMed 文献 · Clin Toxicol (Phila) · 2022-11-04
一句话结论文拉法辛过量者中34.1%发生低血糖,且与剂量相关(Spearman -0.47),低血糖与癫痫发作和住院时间延长相关,作者认为应考虑监测血糖。

这项单中心回顾性队列研究纳入12年间非糖尿病、实验室确认的抗抑郁药过量患者525例,其中文拉法辛85例。文拉法辛暴露与低血糖显著相关(校正OR 6.6,95%CI 3.5-12.6),低血糖发生率34.1%(29/85),高于其他抗抑郁药的10.7%(47/440);文拉法辛组血糖与剂量呈显著负相关(Spearman -0.47,p=0.002)。低血糖以轻度(血糖51-70 mg/dL,75.8%)和中度(31-50 mg/dL,20.7%)为主,严重低血糖1例(血糖30 mg/dL)。无论是否暴露文拉法辛,低血糖均与癫痫发作(校正OR 5.3,95%CI 2.6-10.6)和住院时间延长2.7天(95%CI 1.3-4.2)相关。作者认为文拉法辛过量时应考虑监测血糖。

要点

  • 文拉法辛过量者低血糖发生率34.1%(29/85),其他抗抑郁药过量者为10.7%(47/440),校正OR 6.6(95%CI 3.5-12.6)。
  • 文拉法辛组血糖与剂量显著负相关(Spearman -0.47,p=0.002),其他常用抗抑郁药无此剂量依赖性。
  • 文拉法辛相关低血糖以轻度(血糖51-70 mg/dL,75.8%)和中度(31-50 mg/dL,20.7%)为主,严重低血糖(血糖30 mg/dL)1例。
  • 无论是否文拉法辛暴露,低血糖与癫痫发作相关(校正OR 5.3,95%CI 2.6-10.6),并与住院时间延长2.7天(95%CI 1.3-4.2)相关。
  • 作者认为文拉法辛过量时应考虑监测血糖。

适用人群与场景

  • 非糖尿病、实验室确认抗抑郁药过量的患者,就诊于三级医院临床毒理科,研究期12年。
  • 包括多药暴露者。

诊断标准与关键阈值

  • 低血糖程度按血糖值分级:轻度血糖51-70 mg/dL,中度血糖31-50 mg/dL,重度血糖30 mg/dL。

红旗征与不能漏的情况

  • 文拉法辛过量患者出现低血糖时,需警惕癫痫发作(校正OR 5.3,95%CI 2.6-10.6)和住院时间延长(增加2.7天,95%CI 1.3-4.2)。
  • 文拉法辛相关低血糖虽以轻中度为主,但研究中有1例严重低血糖(血糖30 mg/dL)。

研究设计与关键结果

  • 单中心回顾性队列研究,纳入525例抗抑郁药中毒,其中文拉法辛暴露85例。
  • 主要终点低血糖:文拉法辛组34.1%(29/85) vs 非文拉法辛抗抑郁药组10.7%(47/440);文拉法辛暴露与低血糖显著相关,校正OR 6.6(95%CI 3.5-12.6)。
  • 文拉法辛组血糖与剂量显著负相关(Spearman相关系数-0.47,p=0.002),其他常用抗抑郁药无显著剂量依赖性。
  • 文拉法辛相关低血糖严重程度:轻度(血糖51-70 mg/dL)占75.8%,中度(血糖31-50 mg/dL)占20.7%,严重低血糖(血糖30 mg/dL)1例。
  • 无论是否文拉法辛暴露,低血糖与癫痫发作相关(校正OR 5.3,95%CI 2.6-10.6),并与住院时间延长2.7天(95%CI 1.3-4.2)相关。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,文拉法辛过量时应考虑监测血糖。
  • 文拉法辛过量患者出现低血糖时,应关注癫痫发作和住院时间延长的可能,但作者指出这些因素可能主要由其他毒性决定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Several case reports describe hypoglycemia in the context of venlafaxine overdose, while investigations at therapeutic dose suggested a neutral effect on glucose homeostasis. Studies on hypoglycemia in venlafaxine intoxication are lacking.

METHODS: Single-center retrospective cohort study of non-diabetic patients presenting with a laboratory-confirmed antidepressant overdose to the department of clinical toxicology of a tertiary care hospital over a 12-year period. Our main goal was to investigate the association of hypoglycemia as the primary outcome with venlafaxine exposure using multiple logistic regression. Multi-drug exposures were included. We further aimed to describe the association of blood glucose (BG)/hypoglycemia with antidepressant dose, seizures and length of hospital stay.

RESULTS: 525 antidepressant intoxications were included, 85 of which involved venlafaxine. Hypoglycemia occurred in 34.1% (29/85) of venlafaxine intoxications and in 10.7% (47/440) of non-venlafaxine antidepressant overdoses. Venlafaxine exposure was significantly associated with hypoglycemia (adjusted odds ratio (OR): 6.6, 95% confidence interval (CI): 3.5-12.6). Venlafaxine-associated hypoglycemia was mainly mild (BG: 51-70 mg/dL), in 75.8% of cases, to moderate (BG: 31-50 mg/dL), in 20.7%, with one case of severe hypoglycemia (BG: 30 mg/dL). BG was significantly inversely correlated with dose in the venlafaxine group (Spearman's correlation coefficient: -0.47, p = 0.002) but not in other commonly prescribed antidepressants. Regardless of venlafaxine exposure, hypoglycemia was associated with seizures (adjusted OR: 5.3, 95% CI: 2.6-10.6) and with a 2.7 day increase in hospital length of stay (95% CI: 1.3-4.2).

CONCLUSION: A dose-related, mild to moderate hypoglycemia occurred in over one-third of venlafaxine poisonings. In overdose of other antidepressants, hypoglycemia was seen less frequently and without significant dose-dependency. Regardless of venlafaxine exposure, hypoglycemia was associated with seizures and prolonged length of stay, although these factors are likely primarily determined by other toxicities. BG monitoring in venlafaxine overdose should be considered.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Bekka E, Eyer F. Dose-related hypoglycemia in venlafaxine poisoning: a retrospective cohort study. Clin Toxicol (Phila). 2022. PMID: 36332110. doi:10.1080/15563650.2022.2138762

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。